Summary & Overview
HCPCS Q1004: New-Technology Intraocular Lens, Category 4
HCPCS Level II code Q1004 designates a new-technology intraocular lens in category 4, used to report advanced implantable lens devices for ophthalmic surgery. This code matters nationally as it standardizes reporting for novel intraocular lens technologies, enabling consistent billing and policy consideration across payers and care settings. Standardized codes like Q1004 support coverage reviews, pricing decisions, and tracking of new device adoption.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context, typical sites of service, and the payers commonly involved in coverage decisions. The publication covers benchmarks and policy-relevant points such as how the code is positioned for new-technology lenses, implications for surgical billing in ambulatory surgical centers and hospital outpatient departments, and the role of HCPCS coding in payer evaluation of innovative ophthalmic devices.
The document also highlights areas where input data is not available and identifies topics for further review, including specific coverage policies, associated ICD-10 diagnoses, and related codes. This summary provides a national perspective for clinicians, administrators, and policy analysts seeking clarity on reporting and administrative handling of new intraocular lens technologies.
Billing Code Overview
HCPCS Level II code Q1004 represents a new technology intraocular lens, category 4, as defined in the Federal Register notice. This code is used to identify advanced intraocular lens technology that falls within the category 4 designation for reporting and billing purposes.
Service Type: Implantable intraocular lens device placement
Typical Site of Service: Ambulatory surgical center or hospital outpatient department (ophthalmic surgical setting)
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with visually significant cataract presents for cataract extraction with intraocular lens (IOL) implantation. The surgeon elects to implant a New Technology Intraocular Lens classified as category 4 under the federal register notice for improved postoperative visual function beyond standard monofocal lenses. The clinical workflow includes preoperative evaluation with history, slit-lamp and dilated fundus exam, biometric measurements (axial length and keratometry), informed consent discussing benefits and risks of the new technology IOL, scheduling the cataract procedure, standard phacoemulsification cataract extraction in an ambulatory surgery center or hospital outpatient department, implantation of the Q1004 lens during the procedure, and routine postoperative follow-up visits to assess visual acuity and refractive outcome. Typical sites of service include ambulatory surgery centers (ASC) and hospital outpatient departments. Payers involved may include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare depending on patient coverage and benefit design.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no specific modifier applies to the service. |